Digg It - Business

This might be a given for some people, but it still needs to be said. If someone has not sp

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ecifically asked for your information, don't send it. Simple as that. Not only are you wast

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ing time, you are wasting money as well. It could also have an impact on your image, so jus

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

t don't do it.

Often times on message board was see someone simply say "I want to work for

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

home" and is bombarded with offers. The correct thing to do in this situation is to first

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ind out what kind of interests they have. You may want them as a recruit, but you don't wan

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

t them if they have zero interest in your products and will quit in just a few short months

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

.

Another example of a wrong time to promote was a snail mail we received. This person had

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

good intentions I'm sure, but what they did not realize is we have other businesses. The b

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

usiness information this person sent was in direct conflict with one of these other busines

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

es. If you were a Mary Kay rep, would you purposely send business information to an Avon re

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

p? I would hope not, but it's amazing how many do this every day without realizing it.

Fin

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ally another point we need to bring up is articles. While they are a far cry from business

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

information and don't even fall into the same category, we can't tell you how many articles

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

we get a day that have absolutely nothing to do with our publication. If you write article

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

, which you should in any business, make sure you know where your articles are going. Garde

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ning has nothing to do with a business newsletter, so don't send it there. Read publisher g

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

uidelines, and the publication if you can before submitting. Avoid auto submissions that do

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

n't tell you where your article is going.

The bottom line is - if it's not asked for, don'

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

t send it! Your reputation, time, and money are at risk when you send information at random

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/28673/diggit-The-Wrong-Time-to-Promote.html">The Wrong Time to Promote?</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/28673/diggit-The-Wrong-Time-to-Promote.html]The Wrong Time to Promote?[/url]

Graphic design is a field that is rising in possibilities for artistically creative mind...

As with any organised event which involves schedules and deadlines, the planning and execution of an exhibition takes a lot of coordination and dedication in order for it to be successful. There are various steps that need to be completed in order for the exhibition to run smoothly, the majority of which are based around the exhibition planning team and coordinator. Exhibitions are primarily aimed at sharing something with a wider community, be it art, motor vehicles, music technology or lingerie. It is therefore essential that the aim and vision of the exhibition be clear and precise, in order to reach the target audience with full effect.

Tags

Links

Digg It - The Wrong Time to Promote?

Related Articles: